Drawing for ALUME

USPTO serial 90156875

ALUME

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BLACK, MILDRED ELIZABETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALUME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michelle L. Mehok

Michelle L. Mehok Pillsbury Winthrop Shaw Pittman LLP11682 El Camino Real, Suite 200San Diego, CA 92130United States

Goods and services

ClassDescriptionStatusFirst use
010Surgical and medical devices and instruments, namely, fluorescent visualization devices, instruments, and components for use in conjunction with pharmaceutical preparations during surgical or medical procedures; Surgical and medical devices and instruments, namely, endoscopes, surgical loupes, endoscopy cameras for medical purposes, and robotic imaging components, adapted for fluorescent visualization, for use in conjunction with pharmaceutical preparations during image-guided surgical or medical procedures; Surgical and medical devices and instruments, namely, fluorescence visualization devices, instruments, and components for use in conjunction with peptide conjugates, namely, peptides linked to a cargo molecule comprising a fluorescent moiety; Surgical and medical devices and instruments, namely, fluorescence visualization devices, instruments, and components for use in conjunction with peptide-fluorescent moiety conjugates; Surgical and medical devices and instruments, namely, fluorescence visualization devices, instruments, and components for use in conjunction with pharmaceutical preparations to visualize nerves during image-guided surgical or medical procedures; Surgical and medical devices and instruments, namely, fluorescence visualization devices, instruments, and components for use in conjunction with pharmaceutical preparations to help avoid nerve damage or facilitate nerve ablation during image-guided surgical or medical procedures; Surgical and medical devices and instruments, namely, fluorescence visualization devices, instruments, and components for use with peptide conjugates to illuminate, label, tag, or target nerves; Surgical and medical devices and instruments, namely, fluorescence visualization devices, instruments, and components, for use in conjunction with pharmaceutical preparations employing targeting peptide conjugates to visualize nerves during image-guided surgical or medical proceduresACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 12, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 1, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 1, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 30, 2023EX5GSOU EXTENSION 5 GRANTED—
Nov 30, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 20, 2023EXT5SOU EXTENSION 5 FILED—
Nov 20, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 27, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 27, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 27, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 18, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 16, 2023EX4GSOU EXTENSION 4 GRANTED—
May 16, 2023EXT4SOU EXTENSION 4 FILED—
May 16, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 16, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 14, 2022EX3GSOU EXTENSION 3 GRANTED—
Nov 14, 2022EXT3SOU EXTENSION 3 FILED—
Nov 14, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 14, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 12, 2022EX2GSOU EXTENSION 2 GRANTED—
May 12, 2022EXT2SOU EXTENSION 2 FILED—
May 12, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 25, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 23, 2021EX1GSOU EXTENSION 1 GRANTED—
Nov 23, 2021EXT1SOU EXTENSION 1 FILED—
Nov 23, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 10, 2021CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Jun 4, 2021APETASSIGNED TO PETITION STAFF—
May 27, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 27, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 25, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 11, 2021EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Mar 30, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 30, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 10, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 23, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 30, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 30, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 30, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 12, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 12, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 5, 2021DOCKASSIGNED TO EXAMINER—
Oct 8, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 7, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance